Volume 14, Issue 1 pp. 43-50
Free to Read

Expression of Major Histocompatibility Complex class l Molecules on the Different Cell Types in Multiple Sclerosis Lesions

R. Höftberger MD

R. Höftberger MD

Division of Neuroimmunology, Brain Research Institute, University of Vienna, Austria

Contributed equally to this study.

Search for more papers by this author
F. Aboul-Enein MD

F. Aboul-Enein MD

Department of Neurology, Hospital SMZost, Vienna, Austria

Contributed equally to this study.

Search for more papers by this author
W. Brueck MD

W. Brueck MD

Department of Neuropathology, Georg-August-UniversitÅO0ä1 t, GÅoã2ttingen, Germany

Search for more papers by this author
C. Lucchinetti MD

C. Lucchinetti MD

Department of Neurology, Mayo Clinic, Rochester, US

Search for more papers by this author
M. Rodriguez

M. Rodriguez

Department of Neurology, Mayo Clinic, Rochester, US

Search for more papers by this author
M. Schmidbauer MD

M. Schmidbauer MD

Department of Neurology, Hospital Lainz, Vienna, Austria

Search for more papers by this author
K. Jellinger MD

K. Jellinger MD

Institute for Clinical Neurobiology, Vienna, Austria

Search for more papers by this author
H. Lassmann MD

Corresponding Author

H. Lassmann MD

Division of Neuroimmunology, Brain Research Institute, University of Vienna, Austria

Prof Dr Hans Lassmann, Div. Neuroimmunology, Brain Research Institute; University of Vienna, spialgasse 4, A-1090 Wien, Austria (E-mail: [email protected])Search for more papers by this author
First published: 05 April 2006
Citations: 189

Abstract

Multiple sclerosis is considered to be an immune-mediated disease of the central nervous system, characterized by chronic inflammation, primary demyelination and axonal damage. The mechanisms of demyelination and axonal injury are heterogeneous and complex. One possible mechanism is direct damage of oligodendrocytes and neurons by Class I MHC restricted cytotpxic T-cells. In this study we analyzed the expression of functional MHC class I molecule complex, consisting of α-chain and β2-microglobulin, in a large sample of human autopsy material, containing 10 cases of acute MS, 10 cases of chronic active MS, 10 cases of chronic inactive MS and 21 controls. To examine the expression of MHC class I and II molecules on the different cell-types in brain, we used quantitative immunohistochemical techniques, double staining and confocal laser microscopy scans on paraffin embedded sections. We found constitutive expression of MHC class I molecule on microglia and endothelial cells. A hierarchical up-regulation of MHC class I was present on astrocytes, oligodendrocytes, neurons and axons, depending upon the severity of the disease and the activity of the lesions MHC class II molecules were expressed on microglia and macrophages, but not on astrocytes. These data indicate that in MS lesions all cells of the central nervous system are potential targets for Class I MHC restricted cytotoxic T-cells.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.